Introduction 17
The poor recovery of damaged cartilage has prompted researchers to develop a define regeneration strategy [1] . 18
The repair technique used for articular cartilage is mostly done using various cell sources with limited 19 propagating ability. Chondrocytes are usually obtained autologously or generated in vitro from adult stem cells 20 (i.e., adipose-derived stem cells and mesenchymal stem cells) [2, 3] . However, primary chondrocytes and adult 21 stem cells are in short supply and easily lose its characteristics under in vitro culture conditions. It is also 22
reported that the chondrogenic potential of the adult stem cells depends on the pathological status of the donor. 23
Over the past decade, human induced pluripotent stem cells (hiPSCs) have shown boundless possibilities in 24 tissue regeneration. hiPSCs expand significantly and maintain their pluripotency for several passages [4] . The 25 absorbance of recombinant protein BMP2 (conc. 0.1 ng/mL) ( Figure 1E ). The protein expression of mcTGFβ3 1 was relatively low ( Figure 1F ). However, compared to the supernatant of mcMock, the absorbance was detected 2 in the supernatant of mcTGFβ3-transfected HEK293T cells. Based on these results, we confirmed the successful 3 cloning of growth factor-encoding minicircles. 4 mcBMP2-transfected HEK293T cell supernatant was high as much as the commercial 5 
Chondrogenesis with minicircles using human iPSC-derived OG cells 1
hiPSCs were generated into EBs for OG induction. Mesenchymal-like OG cells were induced from the EBs 2 for transfection. Minicircle vectors were transfected in OG cells one day before chondrogenic differentiation 3 using pellet culture system. The chondrogenic pellets were maintained for 30 days without recombinant growth 4 factor addition to observe the differentiation efficacy of mcBMP2 and mcTGFβ3 (Figure 2A ). Stable hiPSCs 5 with a compact colony were used for differentiation ( Figure 2B ). Cells were aggregated to generate EBs ( Figure  6 2C). After attaching the EBs onto a gelatin-coated dish, fibroblast-like OG cells were induced ( Figure 2D ). After 7 maintaining the OG cells for a week, cells showed a fibrotic morphology that is similar to mesenchymal stem 8 cells. Cells showed a stable morphology after several days before differentiation ( Figure 2E ). Transfection with 9 mcMock in OG cells showed high expression of RFP ( Figure 2F ). Similar to the results of HEK293T cells, 10 mcBMP2 showed relatively low expression of RFP in OG cells ( Figure 2G ). Transfection with mcTGFβ3 11
showed similar results to that of HEK293T cells ( Figure 2H ). We have confirmed that the overall transfection 12 tendency of OG cells were similar to the tendency that was shown from HEK293T cells ( Figure 2I ). The gene 13 expression of MSCs markers were examined in OG cells. Bone marrow-derived MSCs were used as a positive 14 control. CD44 was increased in OG cells, compared to hiPSCs ( Figure 2J ). CD73 was increased in OG cells as 15 well, however, it was significantly lower than that of MSCs ( Figure 2K) . Interestingly, the expression of CD90 16 was higher than that of MSCs ( Figure 2L ). CD105 was observed in OG cells ( Figure 2M ). MSC markers were 17 all increased in OG cells. Yet most of the markers were lower than that of MSCs. MSCs are usually 18 characterized by three-lineage differentiation (i.e. apipocyte, chondrocyte and osteoblast). OG cells successfully 19 differentiated to osteogenic lineage ( Figure 2N ). OG cells were also able to go through adipogenic 20 differentiation ( Figure 2O ). OG cells were able to generate chondrogenic pellets through differentiation with 21 recombinant growth factors ( Figure 2P ). 
Characterization of minicircle-based chondrogenic pellets 15
OG cells were transfected with mcMock, mcBMP2 and mcTGFβ. After transfection, cells were aggregated into 16 pellets for differentiation. Cells transfected with mcBMP2 and mcTGFβ3 were mixed with the same portion,and generated into pellets by centrifugation as well. Transfected cells formed a pellet after 3 days ( Figure 3A) . 1
On day 10, pellets maintained its morphology and RFP expression was confirmed in the three-dimensional 2 pellets ( Figure 3B ). The condensation of mcTGFβ3 pellets was late than others. Pellets were observed under a 3 fluorescence microscope for 30 days. On day 20, mcBMP2 and mcBOTH pellets stayed in a condensed form, 4 however, mcTGFβ3 pellets increased in size ( Figure 3C ). The RFP expression of mcBMP2 and mcTGFβ3 was 5 maintained up to 20 days but decreased when observed on day 30 ( Figure 3D ). The RFP expression of mcMock 6 was maintained until day 30 of differentiation. 7 The characteristics of the generated chondrogenic pellets were analyzed. The gene expression of chondrogenic 7 markers was evaluated. Chondrogenic pellets generated with human recombinant BMP2 and TGFβ3 were used 8 as a control (Both rhGF). The early chondrogenic marker, SOX9 was increased in the chondrogenic pellets 9 differentiated with the minicircle-transfected cells ( Figure 4A ). The expression of ACAN was increased, but as 10 SOX9, it was lower than that of the chondrogenic pellet differentiation with recombinant proteins ( Figure 4B) . 11 SOX9 and ACAN were both significantly increased in mcBMP2, mcTGFβ3, and mcBOTH compared to 12 mcMock. COL2A1 is the gene responsible for the expression of collagen type II. The gene expression of 13 COL2A1 was detected the highest in the minicircle-transfected chondrogenic pellets ( Figure 4C ). The 14 expression was much higher than the pellets generated using recombinant growth factors. The fibrotic marker 15 COL1A1 were higher in the minicircle-transfected chondrogenic pellets, however, the expression of COL10A1 16 was lower than other groups ( Figure 4D and 4E). Interestingly, mcBMP2 had the highest expression of COL1A1, 17 and mcTGFβ3 had the highest expression of COL10A1. Yet, mcBOTH had the most moderate expression of all 18 markers. The osteogenic marker, RUNX2 was measured in pellets to confirm the osteogenesity of chondrogenic 19 pellets ( Figure 4F ). All three conditions showed lower expression of RUNX2 expression compared to the pellet 20 differentiated by recombinant growth factors. Pellets generated with mcBOTH had the lowest expression of 21 RUNX2. The ECM accumulation was detected by toluidine blue staining ( Figure 4G ). Taken all together, we 22 have confirmed the expression of minicircles in the iPSC-derived chondrogenic pellets, and the pellets had the 23 characteristics of the chondrogenic lineage. 
Further analysis of minicircle-based chondrogenic pellets 8
ECM production was detected in all pellets generated with minicircle vectors. For further analyzation, the 9 collagen type that consist the produced ECM was analyzed. Collagen type II represents the hyaline cartilage, 10 and collagen type I represents the fibrotic cartilage in vivo. Negative control is shown in Figure 5A . TheExpression of collagen type II was highly detected even in the cells (blue arrow) of pellets treated with 1 mcBOTH ( Figure 5B ). Collagen type II was also detected in mcMock pellets as well. The expression of 2 collagen type I was also confirmed in pellets ( Figure 5C ). Collagen type 1 was relatively high in mcBMP2 and 3 also in mcMock. Collagen type X is usually expressed in hypertrophic cells. The expression of collagen type X 4 was also the highest in mcBMP2 pellets ( Figure 5D ). 
In vivo transplantation of mcBOTH chondrogenic pellets in osteochondral rat model 12
To confirm the recovery ability of minicircle-transfected chondrogenic pellet, we transplanted the pellets in the 13 defect of an osteochondral rat model ( Figure 6A ). Defects were induced using a microdrill and chondrogenic 14 pellets (day 30) were placed in the defect. Rats were maintained for 8 weeks and sacrificed for further analysis. 15
The recovery was evaluated by several staining methods. Defects treated with minicircle-based chondrogenic 16 pellet were healed, yet, mcBMP2 treated joints showed less accumulation of ECM ( Figure 6B ). The defect in 17 joints implant with mcMock pellets, however, had almost no accumulation of ECM proteins. We examined the 18 protein type that was accumulated in the healed ECM matrix. Negative control is shown in Figure 6C . Collagen 19 type II was highly expressed in joints implanted with mcTGFβ3 and mcBOTH ( Figure 6D ). The two groups had 20 higher expression of collagen type II than that of mcMock treated with both growth factors (Both rhGF). The 1 expression of collagen type I was detected in mcBMP2 implanted joints ( Figure 6E ). Collagen I was barely 2 detected in joints with mcTGFβ3, mcBOTH and Both rhGF. Collagen type X was thought to be highly 3 expressed in mcTGFβ3-implanted joints, however, it seemed similar to that of mcBMP2-implanted joints 4 ( Figure 6F ). Through these results, we confirmed that minicircle-transfected chondrogenic pellets efficiently 5 healed under in vivo conditions. 
Discussion 15
The low cellularity and avascularity limits the ability of cartilage recovery. The current option for cartilagerecovery using cell-based therapy is the use of chondrocytes or MSCs. However, autologous chondrocytes and 1
MSCs lose their original characteristics after several passages under in vitro conditions [29, 30] . 2 Dedifferentiated cells result in fibrocartilage after differentiation or transplantation. This challenge must be 3 overcome for better cartilage recovery using cell-based therapy. 4
Human iPSCs are stem cells generated from the adult somatic cells obtained from the donor. The identical 5 immunity with the donor makes hiPSCs able to avoid immune rejection. hiPSCs can be expanded limitlessly in 6 vitro. Therefore it is a possible candidate as a for the next generation material for cell-based therapy. The use of 7 iPSCs in cartilage regeneration and recovery can suggest options for cell-based therapy to treat cartilage defects. . Co-stimulation with both BMP2 andsynergistically enhance the effect of TGFβ3 [17] . We induced chondrogenesis by transfecting mcBMP2 and 1 mcTGFβ3 into EB-derived outgrowth cells. Separately transfected outgrowth cells were mixed to confirm the 2 effect on co-stimulation of BMP2 and TGFβ3. Co-stimulation with both growth factors showed similar 3 expression of SOX9, COL2A1 compared to that of the other two conditions (Figure 4A and 4B) . However, 4 mcBOTH-transfected outgrowth cells showed low expression levels of COL1A1 and COL10A1. Pellets 5 generated with mcBOTH-transfected cells had the lowest expression of RUNX2 ( Figure 4F ). Previous reports 6 have shown that co-stimulation with both growth factors had lower bone gamma-carboxyglutamate protein 7 (BGLAP, Osteocalcin) compared to either MSCs treated with TGFβ3 or undifferentiated MSCs [17] . These 8 results correspond with the previous reports, suggesting that co-stimulation with both BMP2 and TGFβ3 has the 9 lowest possibilities to develop into bone. 10 ECM was slightly accumulated in mcMock-transfected pellets (Figure 4-5 ). This might be caused by the pellet 11 formation itself, as it is known that a high density of cells can still lead to accumulation of ECM proteins. 12
However, the genetic levels were much higher in growth factor-encoding minicircle transfected pellets, 13 especially aggrecan and collagen type II ( Figure 4B The relative expression of MSC markers (i.e. CD44, CD73, CD90, CD105) was evaluated ( Figure 2J-2M ). OG 22 cells had increased levels of CD44, CD73 and CD105 compared to that of hiPSCs. CD90 was even higher than 23 that of MSCs. OG cells were able to differentiate into all three lineages that are required for MSC 24 characterization (i.e. osteogenic, adipogenic, and chondrogenic differentiation) ( Figure 2N-2P) . The potential to 25 adipogenic lineage seemed to be the weakest in hiPSC-derived OG cells. The characterization of MSCs-derived 26 from hiPSCs was reported by several researchers. It was previously reported by Kang and colleagues that MSCsgenerated from hiPSCs had adequate osteogenicity and chondrogenicity, however, relatively less adipogenicity 1
[38]. There is still less evidence about the low adipogenecity, however there are several other reports that reports 2
the low adipogenesis from hiPSC-derived MSCs and even ESC-derived MSCs [39-41]. 3
MSCs are infamous for having low transfection efficiency with non-viral delivery. Lipid-based non-viral 4 transfection systems showed low efficiency in bone marrow-derived MSCs [42] . These results also agree with 5 the report that shown transfection efficacy lower than 5% in adipose-derived MSCs using lipofectants [43] . 6
Even with minicircles, we previously reported low transfection in bone marrow-derived MSCs using chemical 7 transfection reagents [26] . The transfection efficacy in MSCs was increased when using electroporation along 8 with minicircle vectors. However, MSC-like outgrowth cells derived from hiPSCs showed high transfection 9 efficacy even with lipofectants. This can suggest hiPSCs as a solution for non-viral gene modified cell source 10 for gene and cell therapy. In our results, mcBMP2 showed relatively low transfection rate compared to mcMock 11 or mcTGFβ3. However, the protein secreted from the minicircle did not correlate with the transfection efficacy. 12
Even with low transfection rate, mcBMP2 secreted relatively high levels of growth factor protein than 13 mcTGFβ3. It is thought to be caused by the working structure of the protein. TGFβ3 is reported to have low 14 solubility at physiological pH and form aggregates more easily than the other TGF isoforms [44] . 15
The healing ability of chondrogenic pellets were confirmed in osteochondral defected rat models (Figure 6 ). 16
However, unlike mcTGFβ3 and mcBOTH, mcBMP2 had a relatively small amount of accumulated ECMs. Also, 17 the ECM proteins were expressing collagen type I and X. BMP2 was used as an agent for chondrogenesis, 18 however, it's ultimate function is related with bone generation. The high expression of fibrotic and hypertrophic 19 marker is thought to be related to the calcification of cartilage that can lead to bone formation. Therefore, 20 mcTGFβ3 and mcBOTH are thought to be relatively more applicable for cartilage regeneration for future use. 
Materials and Methods
The minicircle parental plasmid (CMV-MCS-EF1-RFP-SV40-PolyA) was purchased from SBI (System 1 Biosciences, Mountain View, CA, USA). The cDNA sequence of a codon optimized human BMP2 and TGFβ3 2 was subcloned into the mock parental plasmid. The growth factor cDNA was inserted at the BamHI and XbaI 3 restriction sites in the multiple cloning sites downstream to the CMV promoter. The sequence of BMP2 and 4
TGFβ3 is shown in Additional file 1. The minicircle vectors were produced following the manufacturer's 5 instructions. ZYCY10P3S2T E.coli cells were transformed with the parental vectors containing each growth 6 factor. A single colony was obtained and grown for 2 hours in 2 mL of Luria-Bertani broth (LB) with 500 μg/mL 7 kanamycin at 30°C. In a 1 litre flask, 100 μL of starter culture was inoculated into 200 mL terrific broth (TB) 8 and incubated at 30°C with shaking at 200 rpm for 15 hours. Induction medium consisting of 200 mL LB, 4% 9 1N NaOH, and 200 μL of 20% L-arabinose was added to the TB bacterial culture. The mixture was incubated 10
for 5 hours at 30°C with shaking at 200 rpm. Bacterial cells were harvested and plasmid DNA was extracted 11 using NucleoBond Xtra plasmid purification kits (Macherey-Nagel, Duren, Germany). The inserts encoded in 12 the minicircles were confirmed by double digestion in XbaI and BamHI. 13 
hiPSC culture 15
All iPS cell lines used in this experiment (n=3) were generated using cord blood mononuclear cells. 16
Reprogramming and characterization was performed as previously described [4] . Cells were maintained in a 17 vitronectin-coated dish (Thermo Fisher Scientific, Waltham, MA, USA) and media were changed daily with 18 fresh E8 medium (STEMCELL Technologies). 19 20
Embryoid body generation and outgrowth cell induction 21
Maintained iPSCs were detached and 2 x 10 6 cells were prepared. A 1:1 mixture of TeSR-E8 and Aggrewell 22 media (STEMCELL Technologies) was used to generate EBs. Cells were incubated in the media mixture for 24 23 hours at 5% CO2, 37°C. Media were changed daily with fresh E8 media for 3 days. On day 4, EBs were 24 transferred to E7 media. EBs were maintained for additional 3 days. Gelatin-coated dished were prepared for 25 OG cell induction. Culture dishes were coated with 0.1% gelatin for 30 minutes and completely dried. EBs wereharvested and resuspended in OG induction media consisted of Dulbecco's modified eagle medium (DMEM, 1 Thermo Fisher Scientific), 20% Fetal bovine serum (FBS, Thermo Fisher Scientific) and 1% 2 penicillin/streptomycin (Thermo Fisher Scientific). EBs were counted and 50-70 EBs per cm 2 were seeded onto 3 a gelatin-coated dish. OG cells were induced from the attached EBs for 3 days at 5% CO2, 37°C. Next, cells 4 were detached and remaining EB clumps were removed using a 40 μm cell strainer (BD Technologies, Franklin 5
Lakes, NJ, USA). Single OG cells were harvested and plated onto a new gelatin-coated dish (1-5 x 10 4 cell per 6 cm 2 ). Cells were used up to passage 5. 7 8
Minicircle transfection 9
OG cells were seeded onto a gelatin-coated plate. On the day before transfection, culture media were changed 10 to DMEM without serum and antibiotics. Cells were transfected with the minicircle plasmids using . Cells were maintained in osteogenic 4 differentiation media (DMEM supplemented with 15% FBS, 50 μg/ml ascorbate-2-phosphate, 10 nmol/l 5 dexamethasone, and 10 mmol/l β-glycerophosphate) for 21 days with media changed every other day. 6
Osteogenesis was confirmed by alizarin red staining using a commercial kit (Sigma Aldrich, St. Louis, MO, 7 USA). 8 9
Adipogenic differentiation 10
OG cells were seeded onto a gelatin-coated plate at 5x10 4 cells/cm 2 . Cells were maintained in adipogenesis 11 differentiation media (Thermo Fisher Scientific) for 21 days with media changed every other day. Adipogenesis was confirmed by staining with oil red O (Sigma Aldrich). 13 14
Chondrogenic differentiation using pellet culture 15
Minicircle-transfected OG cells were counted and 3 x 10 5 cells per pellet were prepared. Cells were harvested 16 in a 15 mL conical tube and media were changed into chondrogenic differentiation media (CDM; DMEM 17 supplemented with 20% knockout serum replacement, 1x non-essential amino acids, 1 mM L-glutamine, 1% 18 sodium pyruvate, 1% ITS+ Premix, 10 -7 M dexamethasone, 50 mM ascorbic acid, 40 μg/mL L-proline) without 19 additional recombinant growth factors. Cells resuspended in CDM were centrifuged at 750 xg for 5 minutes. 20 Generated pellets were maintained for 30 days and media were changed every 3 days. As a positive control, 21 pellets were supplemented with 10 ng/mL recombinant human TGFβ3 and 50 ng/mL recombinant human BMP2 22 as described in our previous work [5] . 
Polymerase chain reaction 1
Harvested chondrogenic pellets were stored at -80°C before use. Samples were snap-frozen with liquid 2 nitrogen and ground using a pestle. Ground chondrogenic pellet samples were incubated with Trizol (Thermo 3
Fisher Scientific) and mRNA was extracted. RevertAid TM First Strand cDNA Synthesis kit (Thermo Fisher 4 Scientific) was used to synthesize cDNAs from the extracted RNAs. Mean cycle threshold values from triplicate 5 experiments were used to calculate the gene expression normalized to GAPDH as an internal control. Real-time 6 PCR was carried out using LightCycler® 480 Instrument II (Roche, Basel, Switzerland). 7 8
Ethics 9
All procedures involving animals were in accordance with the Laboratory Animals Welfare Act, the Guide for 
Osteochondral defect model 16
Sprague-Dawley rats were anaesthetized. An osteochondral defect (1.5 mm x 1.5 mm x 1.5 mm) was created 17 using a microdrill on the articular cartilage of the trochlear groove of the distal femur. After 10 days of in vitro 18 differentiation, chondrogenic pellets were placed in the defect. The arthrotomy and skin were closed with 19 interrupted nylon sutures. After 4 weeks, rats were sacrificed for gross and histological analysis. The recovery 20 was examined using the International Cartilage Repair Society (ICRS) scoring system. 21 
Histological analysis 23
were fixed in 4% paraformaldehyde for 2 hours at room temperature (RT). Dehydration was performed with 1 increasing sequential ethanol solutions. Additional clearing was done with sequential ethanol-zylene mixtures 2 and samples were infilterated with paraffin overnight. Paraffin blocks were fixed and 7 μm sections were 3 obtained using a microtome. Before staining the sections, slides were placed in a 60°C oven for at least 10 4 minutes. Slides were immediately deparaffinized using zylene. Slides were rehydrated with decreasing 5 sequential ethanol series and were rinsed with running tap water for 1 minute each. For alcian blue staining, 6 slides were incubated in 1% alcian blue solution (Sigma Aldrich) for 30 minutes at RT. Slides were washed with 7 running tap water and counterstained with nuclear fast red solution. For safranin O staining, slides were stained 8 with Weigert's hematoxylin (Sigma Aldrich) for 10 minutes at RT. Slides were washed in running tap water for 9 10 minutes. Slides were stained with 0.001% fast green solution (Sigma Aldrich) and 0.1% safranin O (Sigma 10 Aldrich) solution for 5 minutes each. Toluidine blue staining was done by incubating the hydrated slides in 0.04% 11 toluidine blue (Sigma Aldrich) solution for 10 minutes. Slides were washed in running tap water and dried for 12 10 minutes until complete dryness. After the staining process, slides were dehydrated with an increasing 13 sequential ethanol series. Ethanol was cleared with 2 cycles of 100% zylene and slides were mounted with 14
VectaMount
TM Permanent Mounting Medium (Vector Laboratories, Burlingame, CA, USA). 15 16
Immunohistochemistry 17
Slides were placed in a 60°C oven for 10 minutes and deparafinized with 2 cycles of zylene. Slides were 18 rehydrated and incubated in boiling citrate buffer (Sigma Aldrich) for antigen unmasking. After cooling the 19 unmasked slides, endogenous peroxidase activity was blocked by treating the slides with 3% hydrogen peroxide 20 (Sigma Aldrich). Slides were washed and blocked with tris-buffered saline (TBS) containing 1% bovine serum 21 albumin (BSA). Primary antibodies were diluted in blocking solution in the following ratios: collagen type I 22 Vector Laboratories) diluted in blocking buffer was treated for 40 minutes at RT. After washing out the 25 secondary antibody, slides were treated with ABC reagent drops (Vector Laboratories) for 30 minutes. DAB 26 solution (Vector Laboratories) was followed and incubated for 5 minutes. Slides were washed andcounterstained with Mayer's hematoxylin (Sigma Aldrich) for 1 minute. Slides were dehydrated and cleared. 1 Slides were mounted, and staining was confirmed under a bright field microscope. 2 3
Statistical analysis 4
The results are shown as mean and standard error of the mean. Error bars represent the standard error of the 5 mean. Statistical analysis was performed and graphs were drawn using GraphPad Prism 5 (GraphPad). T-test 6 was applied to analyze non-parametric quantitive datasets, and the one-tailed p-value was calculated. *: p<0.05; 7 **: p<0.01; ***: p<0.001 indicated statistical significance. 8 9 10
Conclusions 11
We conclude that the minicircle encoding human BMP2 and TGFβ3 induced chondrogenesis in hiPSC-derived 12 OG cells. Pellets generated with OG cells transfected with both mcBMP2 and mcTGFβ3 had the highest 13 efficacy of differentiation. Differentiation using human growth factors secreted from minicircles suggests a new 14 regeneration process that can offer in vitro tissue generation. Especially in combination with hiPSCs, this study 15 suggests a new strategy for future regenerative medicine. 16 17
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